| 1 |
30004136 | Inhibition of transcription factor SP1 produces neuroprotective effects through decreasing MAO B activity in MPTP/MPP+ Parkinson's disease models. | 2018 Oct |
1 |
| 2 |
16985099 | Metabolic aromatization of N-alkyl-1,2,3,4-tetrahydroquinoline substructures to quinolinium by human liver microsomes and horseradish peroxidase. | 2006 Dec |
1 |
| 3 |
17447416 | Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells. | 2006 |
1 |
| 4 |
16099847 | Role of the redox protein thioredoxin in cytoprotective mechanism evoked by (-)-deprenyl. | 2005 Nov |
2 |
| 5 |
14962063 | Effect of melatonin on temporal changes of reactive oxygen species and glutathione after MPP(+) treatment in human astrocytoma U373MG cells. | 2004 Mar |
1 |
| 6 |
12044541 | Role of hydroxyl radical formation in neurotoxicity as revealed by in vivo free radical trapping. | 2002 Jun 14 |
1 |
| 7 |
12866710 | Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines. | 2002 Nov-Dec |
1 |
| 8 |
11172770 | SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. | 2001 Feb 23 |
2 |
| 9 |
11233301 | [Parkinsonism induced by MPTP and free radical generation]. | 2001 Feb |
1 |
| 10 |
8627546 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease. | 1996 May |
1 |
| 11 |
8959985 | Oxidative stress and the pathogenesis of Parkinson's disease. | 1996 Dec |
1 |
| 12 |
8071874 | 1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies. | 1994 Aug |
1 |
| 13 |
1815982 | MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. | 1991 Dec 12 |
1 |
| 14 |
2244915 | A new class of powerful inhibitors of monamine oxidase A. | 1990 Nov 15 |
2 |
| 15 |
2253761 | Mechanism of the neurotoxicity of MPTP. An update. | 1990 Nov 12 |
1 |
| 16 |
2543694 | [The effects of 1-methyl-4-phenylpyridine (MPP+) on O2- generation by neutrophils]. | 1989 Feb |
1 |
| 17 |
2753987 | [A new procedure for the determination of N-methylisoquinolinium ion, and its application]. | 1989 Jun |
2 |
| 18 |
3258013 | Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blocker. | 1988 |
2 |
| 19 |
2884568 | Evidence for neuromelanin involvement in MPTP-induced neurotoxicity. | 1987 May 28-Jun 3 |
1 |
| 20 |
3494215 | Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine. | 1987 Jan 27 |
1 |
| 21 |
3556086 | The significance of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. | 1987 |
1 |
| 22 |
3097254 | (-)Deprenyl in perspective: prophylaxis for Parkinson's disease? | 1986 |
1 |
| 23 |
3875815 | Conversion of the neurotoxic precursor 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine into its pyridinium metabolite by human platelet monoamine oxidase type B. | 1985 Jun 24 |
2 |